Novo Nordisk tests lower-dose Wegovy pill
Novo Nordisk has begun a late-stage trial testing lower doses of its oral Wegovy pill. The placebo-controlled trial, called OASIS 5, began enrolling patients Aug. 12 and will compare two undisclosed lower doses of oral semaglutide with placebo in about 450 adults with obesity or overweight across 62 sites in the U.S. and Europe. The […] The post Novo Nordisk tests lower-dose Wegovy pill appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.